Corus declares quarterly dividend of $0.03 for Class B shareholders and $0.02875 for Class A shareholders; adopts a revised dividend payment schedule TORONTO, March 6, 2023 /PRNewswire/ – Corus Entertainment Inc. (TSX: CJR.B) (“Corus” or the “Company”) announced today that its Board of…
Month: March 2023
LONDON, March 6, 2023 /PRNewswire/ — Aquadrill LLC (“Aquadrill” or the “Company”) and a subsidiary of Vantage Holdings International (the “Manager”) have reached an agreement to provide the Capella, an MPD outfitted 6th generation drillship, for a one well contract for operations in East…
LONDON, March 6, 2023 /PRNewswire/ — Aquadrill LLC (“Aquadrill” or the “Company”) and a subsidiary of Vantage Holdings International (the “Manager”) have reached an agreement to provide the Capella, an MPD outfitted 6th generation drillship, for a one well contract for operations in East…
CEDAR RAPIDS, Iowa, March 6, 2023 /PRNewswire/ — Stamats Communications, Inc. is proud to announce the celebration of our 100-year anniversary. Founded in 1923, Stamats has grown from a small publishing company to a leading full-service digital marketing and research agency with a…
BUENOS AIRES, Argentina, March 6, 2023 /PRNewswire/ — Banco BBVA Argentina S.A (NYSE; BYMA; MAE: BBAR; LATIBEX: XBBAR) (“BBVA Argentina” or “BBVA” or “the Bank”) announced today its consolidated results for the fourth quarter (4Q22), ended on December 31, 2022. As of January 1, 2020, the…
SEATTLE, March 6, 2023 /PRNewswire/ — CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, today announced that an authorized subcommittee of the Compensation…
ROGERS, Ark., March 6, 2023 /PRNewswire/ — Unknown Golf, LLC and Island Ventures Inc. announced today that Island Ventures acquired a strategic ownership interest in Unknown Golf. Unknown Golf offers an easy-to-use yet sophisticated platform for managing golf tournaments, league events,…
SAN DIEGO, March 6, 2023 /PRNewswire/ — Mirati Therapeutics, Inc. (NASDAQ: MRTX), a commercial stage biotechnology company, will participate at the Barclays Global Healthcare Conference on March 14 at 6:00 a.m. P.T. / 9:00 a.m. E.T. Ben Hickey, chief commercial officer, and Alan Sandler,…
Fourth Quarter Concludes Successful Transformational Year, With Company Sharpening Focus and Laying a Foundation for Sustainable, Profitable Growth Recently Completed Sales of SinfoníaRx and DoseMe Shares Full Year 2023 Revenue Guidance and Adjusted EBITDA Guidance MOORESTOWN, N.J., March…
SAN DIEGO, March 6, 2023 /PRNewswire/ — Denovo Biopharma LLC (“Denovo”), a pioneer in applying precision medicine to the development of innovative therapies, set up a gene registry web portal and invites people who suffer from treatment-resistant depression (TRD) to visit…